© 2022 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.
© 2022 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
August 10, 2022
Smaller dose given by intradermal injection creates five-fold increase in total supply, FDA says.
August 09, 2022
Both higher fetal and infant weight growth patterns are linked to early markers of impaired arterial health, according to a study published in JAMA Network Open.
August 08, 2022
A study published in JAMA Network Open found that maternal prepregnancy obesity in the United States is associated with an elevated risk of severe maternal morbidity (SMM) and/or mortality.
Correct terms and education can help normalize the conversation for patients.
Oteseconazole is a treatment option for those living with a previously unmet medical need.
August 05, 2022
Myovant Sciences and Pfizer announces the US Food and Drug Administration has approved Myfembree (relugolix combination tablets) for the once-daily treatment of moderate-to-severe endometriosis-associated pain.